Overall rank by patents
#1,434
Across all tracked assignees
USPTO PatentsView assignee record - 291 granted patents across 55 technology areas, active 2015–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR).
The verdict
Intermolecular holds 291 US patents across 55 technology areas, rank #1,434 of 50,000 tracked assignees.
Intermolecular, Inc. has been granted 291 US utility patents between 2015 and 2021, placing Intermolecular, Inc. at rank #1,434 across all assignees tracked by PlainPatent. This portfolio spans 55 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.5 claims per patent with primary concentration in H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR). As a US Corporation, Intermolecular, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Intermolecular sits between University Of Washington Through Its Center For Commercialization (293 patents, rank #1,430) and Dialog Semiconductor Inc. (290 patents, rank #1,438) - the closest US assignees by grant volume. The composite Innovation Score of 54.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 288 in the 2015–2019 window, a -99% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Intermolecular, Inc.'s 16.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 55 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Intermolecular, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
University of Washington through its Center for Commercialization
293 patents
BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
292 patents
GROHE AG
292 patents
Group14 Technologies, Inc.
292 patents
National Research Council of Canada
291 patents
POULSEN ROSER A/S
291 patents
TOMY COMPANY, LTD.
291 patents
INTERMOLECULAR, INC.
291 patents
DIALOG SEMICONDUCTOR INC.
290 patents
What this shows Intermolecular holds 291 patents at rank #1,434, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,434 in granted patent volume.
Other assignees with the most granted patents in Intermolecular's primary technology class.
Intermolecular's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
55 Top 8% higher than 92% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 182 | 62.5% |
| 2016 | 94 | 32.3% |
| 2017 | 11 | 3.8% |
| 2019 | 1 | 0.3% |
| 2020 | 2 | 0.7% |
| 2021 | 1 | 0.3% |
Top 15 of 55 technology areas
Overall rank by patents
#1,434
Across all tracked assignees
54.5 out of 100
How to use this portfolio
Intermolecular's 291 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.